Viewing Study NCT06053658


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-01-01 @ 11:16 AM
Study NCT ID: NCT06053658
Status: RECRUITING
Last Update Posted: 2025-09-05
First Post: 2023-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module